Markets › India › NSE › EMCURE

Emcure Pharmaceuticals Ltd

NSE:EMCUREHealthcareNSE:CNX500NSE:NIFTY500_EW

₹1,766.60−2.97%At closeAt close · Mon 19 Oct · ≈ AED 68.26 · Market cap $3.64B · Next earnings Tue 3 Nov

INR billions	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025	YoY
Net income	—	—	—	—	9.7	9.2	−4.8%
Depreciation & amortization	3.2	—	2.6	3.1	3.8	4.2	+8.0%
Stock-based compensation	—	—	—	—	0.0	0.0	+42.2%
Change in working capital	(3.3)	—	(2.9)	0.5	(4.2)	(5.3)	−24.9%
Operating cash flow	5.3	—	5.7	9.1	8.5	8.5	−0.1%
Capital expenditure	(1.5)	—	(4.0)	(3.1)	(4.1)	(3.6)	+11.4%
Acquisitions	—	—	—	—	0.0	(7.2)	—
Investing cash flow	—	—	—	—	(0.9)	(11.9)	−1171.1%
Dividends paid	(0.2)	—	(0.4)	(0.6)	0.0	(0.6)	—
Share buybacks	—	—	—	—	0.0	0.0	—
Debt issued / repaid	—	—	—	—	(0.2)	5.5	+3453.4%
Financing cash flow	—	—	—	—	(8.1)	4.4	+153.8%
Free cash flow	4.0	1.8	1.8	6.3	4.4	4.9	+10.2%
Net change in cash	—	—	—	—	(0.6)	(0.1)	+86.3%